
Ryvu Therapeutics
Develop therapeutics that address clinical limitations of current treatments in oncology.
Enterprise value
$144m
Share price
PLN29.20 RVU.WA
Company register number
Authorizing premium user...
Develop therapeutics that address clinical limitations of current treatments in oncology.